Glaxo Loses Patent For Seretide/Advair In U.K.
By Marius Meland ( March 19, 2004, 12:00 AM EST) -- GlaxoSmithKline has lost a U.K. patent challenge from generic drug makers Cipla and Ivax on its top-selling athma drug Seretide (Advair)....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.